Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma

Completed · Phase 4

Conditions studied: Allergic Asthma

In brief

The purpose of this study is to determine the role of versican and hyaluronan measurements in induced sputum as biomarkers of asthma. Enroll 10 subjects with mild persistent asthma who are not receiving treatment with a controller therapy.

Key facts

Study ID

NCT00980707

Run by

Associated Scientists to Help Minimize Allergies

People needed

10

Starts

2009-08-01

Expected to finish

2010-11-01

Last updated by the study team

2012-01-19

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Allergic asthma defined as a positive methacholine challenge

You may not qualify if…

• Non-atopic patients

Where it is running

• Associated Scientists to Help Minimize Allergies — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.